Dr. Mucke is the owner and chief executive of H.M. Pharma Consultancy (www.hmpharmacon.com; established in 2000), a provider of consulting services with headquarters in Vienna (Austria). Dr. Mucke has published about 35 strategic evaluation reports on selected pharmaceutical markets (including corporate risk management and patenting strategies) and on drug discovery and development technologies (including predictive safety aspects, adaptive clinical trials, risk management, and data mining). As a scientist, he has authored or co-authored more than 50 peer-reviewed publications in molecular biology, immunology, neurology/psychiatry, cardiorespiratory medicine and ophthalmology with a focus on drug development and patenting. Prior to founding H.M. Pharma Consultancy Dr. Mucke was Chief Science Officer and executive director at Sanochemia Pharmazeutika AG of Austria (1987-1999) where he was responsible for scientific and medical affairs management, strategic intellectual property management, and for work with the US Food and Drug Administration. Before this 13-year period Dr. Mucke had been a research assistant at the University of Vienna, and later a research fellow at Sandoz.
Biography Updated on 14 April 2011